Oncology Central

PARK2 gene and familial lung cancer: what is the link?


PARK2 has tumor suppressive role in cancer

In general, Parkinson’s disease (PD) is a disease of older population. However, there are approximately 4% patients starting PD symptoms at age of 45 years or younger; and it is called early-onset Parkinson’s disease. PARK2 was identified as one of the causal factors of early-onset Parkinson’s disease that is under a recessive mode of inheritance [1].

PARK2 spans 1.36 Mb and comprises 12 small exons with a final processed transcript of 2.3 kb in size. Hence, the PARK2 gene is a typical example of extremely large genes encoding relatively small final processed transcripts.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.